Anticoagulantes Orais Diretos versus Antagonistas da Vitamina K para Trombo Ventricular Esquerdo: Uma Metanálise com Análise Sequencial de Ensaios

Simple item page
dc.contributor.authorEric Pasqualotto
dc.contributor.authorDouglas Mesadri Gewehr
dc.contributor.authorRafael Oliva Morgado Ferreira
dc.contributor.authorMatheus Pedrotti Chavez
dc.contributor.authorCaroliny Silva
dc.contributor.authorSara Almeida Cruz
dc.contributor.authorJhonny Limachi-Choque
dc.contributor.authorAmanda Park
dc.contributor.authorMário Sérgio Soares de Azeredo Coutinho
dc.contributor.authorLuiz Fernando Kubrusly
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T21:05:32Z
dc.date.available2026-03-22T21:05:32Z
dc.date.issued2024
dc.descriptionCitaciones: 1
dc.description.abstractDOACs had a similar rate of thromboembolic and hemorrhagic events, as well as thrombus resolution, compared to VKAs in the treatment of LVTs. Rivaroxaban therapy had a significant reduction in thromboembolic events, compared to VKAs.
dc.identifier.doi10.36660/abc.20230738
dc.identifier.urihttps://doi.org/10.36660/abc.20230738
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/85878
dc.language.isopt
dc.publisherSociedade Brasileira de Cardiologia (SBC)
dc.relation.ispartofArquivos Brasileiros de Cardiologia
dc.sourceUniversidade Federal de Santa Catarina
dc.subjectMedicine
dc.subjectGynecology
dc.subjectInternal medicine
dc.subjectGastroenterology
dc.titleAnticoagulantes Orais Diretos versus Antagonistas da Vitamina K para Trombo Ventricular Esquerdo: Uma Metanálise com Análise Sequencial de Ensaios
dc.typereview

Files

Collections

Artículo Científico Publicado